Aprotinin versus desmopressin for patients undergoing operations with cardiopulmonary bypass. A double-blind placebo-controlled study.

MLA

Casas, J. I., et al. “Aprotinin versus Desmopressin for Patients Undergoing Operations with Cardiopulmonary Bypass. A Double-Blind Placebo-Controlled Study.” The Journal of Thoracic and Cardiovascular Surgery, vol. 110, no. 4 Pt 1, Oct. 1995, pp. 1107–17. EBSCOhost, https://doi.org/10.1016/s0022-5223(05)80180-1.

APA

Casas, J. I., Zuazu-Jausoro, I., Mateo, J., Oliver, A., Litvan, H., Muñiz-Díaz, E., Arís, A., Caralps, J. M., & Fontcuberta, J. (1995). Aprotinin versus desmopressin for patients undergoing operations with cardiopulmonary bypass. A double-blind placebo-controlled study. The Journal of Thoracic and Cardiovascular Surgery, 110(4 Pt 1), 1107–1117. https://doi.org/10.1016/s0022-5223(05)80180-1

Chicago

Casas, J I, I Zuazu-Jausoro, J Mateo, A Oliver, H Litvan, E Muñiz-Díaz, A Arís, J M Caralps, and J Fontcuberta. 1995. “Aprotinin versus Desmopressin for Patients Undergoing Operations with Cardiopulmonary Bypass. A Double-Blind Placebo-Controlled Study.” The Journal of Thoracic and Cardiovascular Surgery 110 (4 Pt 1): 1107–17. doi:10.1016/s0022-5223(05)80180-1.